Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Humar

Showing results (121-130 of 235) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR TrialAnders Åsberg, Atul Humar, Halvor Rollag, et al.
Transplantation|November 11, 2010
Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United StatesEmily A Blumberg, Ingeborg A Hauser, Sanja Stanisic, et al.
Xenotransplantation|February 14, 2004
Control of microbial contamination during surgical harvest of pig renal xenograftsAlexander W Tucker, Juliet E Foweraker, Carolyn E Belcher, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 6, 2005
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplantDeepali Kumar, Dean Erdman, Shaf Keshavjee, et al.
Transplantation|December 23, 2004
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipientsRichard B Freeman, Carlos Paya, Mark D Pescovitz, et al.
Plos One|October 17, 2012
An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipientsAdrian Egli, Moacyr Silva, Daire O'Shea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2025
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipientsAjit P Limaye, Marta Crespo, Nassim Kamar, et al.
Ebiomedicine|September 19, 2020
Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantationTerrance J Y Ku, Rafaela V P Ribeiro, Victor H Ferreira, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipientsAtul Humar, Carlos Paya, Mark D Pescovitz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 18, 2018
A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal cultureShahid Husain, Archana Bhaskaran, Coleman Rotstein, et al.
Pageof 24

Showing results (121-130 of 235) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR TrialAnders Åsberg, Atul Humar, Halvor Rollag, et al.
Transplantation|November 11, 2010
Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United StatesEmily A Blumberg, Ingeborg A Hauser, Sanja Stanisic, et al.
Xenotransplantation|February 14, 2004
Control of microbial contamination during surgical harvest of pig renal xenograftsAlexander W Tucker, Juliet E Foweraker, Carolyn E Belcher, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 6, 2005
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplantDeepali Kumar, Dean Erdman, Shaf Keshavjee, et al.
Transplantation|December 23, 2004
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipientsRichard B Freeman, Carlos Paya, Mark D Pescovitz, et al.
Plos One|October 17, 2012
An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipientsAdrian Egli, Moacyr Silva, Daire O'Shea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2025
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipientsAjit P Limaye, Marta Crespo, Nassim Kamar, et al.
Ebiomedicine|September 19, 2020
Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantationTerrance J Y Ku, Rafaela V P Ribeiro, Victor H Ferreira, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipientsAtul Humar, Carlos Paya, Mark D Pescovitz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 18, 2018
A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal cultureShahid Husain, Archana Bhaskaran, Coleman Rotstein, et al.
Pageof 24